CRISPR Therapeutics AG Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | M | 1.81 | 20,000 | 36,200 | 108,983 | |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 217.44 | 1,304 | 283,542 | 182,989 | 184.3 K to 183 K (-0.71 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 216.50 | 1,708 | 369,782 | 184,293 | 186 K to 184.3 K (-0.92 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 214.68 | 1,700 | 364,956 | 186,001 | 187.7 K to 186 K (-0.91 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 213.71 | 5,623 | 1,201,691 | 187,701 | 193.3 K to 187.7 K (-2.91 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 212.75 | 6,525 | 1,388,194 | 193,324 | 199.8 K to 193.3 K (-3.26 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Sell | S | 211.83 | 3,140 | 665,146 | 199,849 | 203 K to 199.8 K (-1.55 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Buy | M | 1.81 | 20,000 | 36,200 | 202,989 | 183 K to 203 K (+10.93 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 14.43 | 16,334 | 235,700 | 14,666 | |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | M | 12.57 | 8,666 | 108,932 | 0 | |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 219.99 | 2 | 440 | 20,000 | 20 K to 20 K (-0.01 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 218.54 | 701 | 153,197 | 20,002 | 20.7 K to 20 K (-3.39 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 217.42 | 9,997 | 2,173,548 | 20,703 | 30.7 K to 20.7 K (-32.56 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 216.39 | 1,500 | 324,585 | 30,700 | 32.2 K to 30.7 K (-4.66 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 214.60 | 700 | 150,220 | 32,200 | 32.9 K to 32.2 K (-2.13 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 213.64 | 2,800 | 598,192 | 32,900 | 35.7 K to 32.9 K (-7.84 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 212.20 | 634 | 134,535 | 35,700 | 36.3 K to 35.7 K (-1.74 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 14.43 | 16,344 | 235,844 | 36,334 | 20 K to 36.3 K (+81.76 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 217.45 | 200 | 43,490 | 20,000 | 20.2 K to 20 K (-0.99 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 216.24 | 400 | 86,496 | 20,200 | 20.6 K to 20.2 K (-1.94 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 214.46 | 1,400 | 300,244 | 20,600 | 22 K to 20.6 K (-6.36 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 213.71 | 1,200 | 256,452 | 22,000 | 23.2 K to 22 K (-5.17 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 212.54 | 2,555 | 543,040 | 23,200 | 25.8 K to 23.2 K (-9.92 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Sell | S | 211.44 | 2,911 | 615,502 | 25,755 | 28.7 K to 25.8 K (-10.15 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 12.57 | 8,666 | 108,932 | 28,666 | 20 K to 28.7 K (+43.33 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | M | 51.49 | 27,500 | 1,415,975 | 12,500 | |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Sell | S | 207.61 | 2,100 | 435,981 | 22,431 | 24.5 K to 22.4 K (-8.56 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Sell | S | 206.05 | 1,800 | 370,890 | 24,531 | 26.3 K to 24.5 K (-6.84 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Sell | S | 205.60 | 8,997 | 1,849,783 | 26,331 | 35.3 K to 26.3 K (-25.47 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Sell | S | 204.40 | 7,818 | 1,597,999 | 35,328 | 43.1 K to 35.3 K (-18.12 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Sell | S | 203.58 | 6,785 | 1,381,290 | 43,146 | 49.9 K to 43.1 K (-13.59 %) |
| Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Buy | M | 51.49 | 27,500 | 1,415,975 | 49,931 | 22.4 K to 49.9 K (+122.60 %) |
| Jan 04 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Payment of Exercise | F | 153.11 | 9,392 | 1,438,009 | 10,608 | 20 K to 10.6 K (-46.96 %) |